Compare BIO & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | GSAT |
|---|---|---|
| Founded | 1952 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.5B |
| IPO Year | N/A | 2006 |
| Metric | BIO | GSAT |
|---|---|---|
| Price | $319.48 | $65.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $358.50 | $52.75 |
| AVG Volume (30 Days) | 156.6K | ★ 1.1M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,557,500,000.00 | $262,202,000.00 |
| Revenue This Year | $1.89 | $10.89 |
| Revenue Next Year | $2.45 | $10.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.54 |
| 52 Week Low | $211.43 | $17.24 |
| 52 Week High | $373.69 | $65.52 |
| Indicator | BIO | GSAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.57 | 67.65 |
| Support Level | $298.35 | $58.02 |
| Resistance Level | $328.07 | $62.68 |
| Average True Range (ATR) | 10.38 | 3.88 |
| MACD | 0.29 | -0.18 |
| Stochastic Oscillator | 60.79 | 99.40 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.